Restart Life Sciences Corp.
NMLSF
Rank in Stocks
#31547
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Share Price
$0.03
Last synced: 2026-11-10
Market Cap
$2.88M
Change (1 day)
97.37%
Change (1 year)
-46.43%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Restart Life Sciences Corp. (NMLSF)
Category
Healthcare
Operating Margin for Restart Life Sciences Corp. (NMLSF)
Operating Margin as of November 2026 TTM: -365.86%
According to Restart Life Sciences Corp.'s latest financial reports, its current operating margin (TTM) is -365.86%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Restart Life Sciences Corp. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -365.86% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -15,703.45% | 0.89% |
| 2019 | -15,564.92% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | 0.00% |
| 2008 | 0.00% | 0.00% |
| 2007 | 0.00% | 0.00% |
| 2006 | 0.00% | -100.00% |
| 2005 | -12,754.10% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.11% |
US
|
|
| -149.01% | -99.59% |
US
|
|
| 25.57% | -100.07% |
AU
|
|
| 31.23% | -100.09% |
BE
|
|
| 29.35% | -100.08% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Restart Life Sciences Corp.'s operating margin
What is Restart Life Sciences Corp.'s operating margin?
Restart Life Sciences Corp.'s operating margin is -365.86%, as of Nov 2026.
What was Restart Life Sciences Corp.'s operating margin in 2025?
In 2025, Restart Life Sciences Corp.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Restart Life Sciences Corp.'s operating margin changed since 2020?
From 2020 to 2025, Restart Life Sciences Corp.'s operating margin was highest in 2025 (0.00%) and lowest in 2020 (-15,703.45%).
How does Restart Life Sciences Corp.'s operating margin compare with similar companies?
Restart Life Sciences Corp.'s operating margin (-365.86%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.